» Authors » Jo A Tucker

Jo A Tucker

Explore the profile of Jo A Tucker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 307
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li E, Butkovich N, Tucker J, Nelson E, Wang S
Methods Mol Biol . 2023 Jun; 2671:321-333. PMID: 37308653
Cancer vaccines displaying tumor-associated antigens (TAAs) train the immune system for enhanced tumor recognition and elimination. Nanoparticle-based cancer vaccines are ingested and processed by dendritic cells, which subsequently activate antigen-specific...
2.
Li E, Brennan C, Ramirez A, Tucker J, Butkovich N, Meli V, et al.
Mater Today Bio . 2022 Oct; 17:100455. PMID: 36304975
Bioluminescence imaging has advantages over fluorescence imaging, such as minimal photobleaching and autofluorescence, and greater signal-to-noise ratios in many complex environments. Although significant achievements have been made in luciferase engineering...
3.
Agbayani C, Tucker J, Nelson E, Martinez F, Cortes H, Khoury D, et al.
Support Care Cancer . 2022 Jan; 30(4):3379-3388. PMID: 34994860
Purpose: Research has shown that parents of children with cancer exhibit an altered immune profile compared to parents of healthy children, reflective of increased susceptibility to illness. These parents are...
4.
Tucker J, Osann K, Hsieh S, Wahi A, Monk B, Wenzel L, et al.
Int J Behav Med . 2021 Feb; 28(1):140-150. PMID: 33598780
Background: Sleep disturbances are associated with numerous mood disorders. Similarly, anxiety and depression are associated with modulation of the psychoneuroimmune (PNI) axis. This study hypothesized that changes in both monitored...
5.
Osann K, Wilford J, Wenzel L, Hsieh S, Tucker J, Wahi A, et al.
Support Care Cancer . 2019 Jan; 27(9):3301-3310. PMID: 30612237
Objective: Benefits of social support (SS) during cancer survivorship are complex. This study examines change in SS over time in cervical cancer (CXCA) survivors who have completed definitive treatment and...
6.
Iyer N, Osann K, Hsieh S, Tucker J, Monk B, Nelson E, et al.
Clin Ther . 2016 Mar; 38(3):467-75. PMID: 26926320
Purpose: Improvement in health behaviors following cancer diagnosis may contribute to better prognosis and well-being. This study examines the prevalence of health behaviors in cervical cancer survivors who have completed...
7.
Wenzel L, Osann K, Hsieh S, Tucker J, Monk B, Nelson E
J Clin Oncol . 2015 Feb; 33(10):1171-9. PMID: 25713429
Purpose: Survivors of cervical cancer experience quality-of-life (QOL) disruptions that persist years after treatment. This study examines the effect of a psychosocial telephone counseling (PTC) intervention on QOL domains and...
8.
Tucker J, Jochems C, Boyerinas B, Fallon J, Greiner J, Palena C, et al.
Cancer Immunol Immunother . 2014 Sep; 63(12):1307-17. PMID: 25186612
The transcription factor brachyury is a major driver of epithelial to mesenchymal transition in human carcinoma cells. It is overexpressed in several human tumor types versus normal adult tissues, except...
9.
Gulley J, Madan R, Tsang K, Jochems C, Marte J, Farsaci B, et al.
Cancer Immunol Res . 2014 Apr; 2(2):133-41. PMID: 24778277
PSA-TRICOM (PROSTVAC) is a novel vector-based vaccine designed to generate a robust immune response against prostate-specific antigen (PSA)-expressing tumor cells. The purpose of this report is to present an overview...
10.
Jochems C, Tucker J, Tsang K, Madan R, Dahut W, Liewehr D, et al.
Cancer Immunol Immunother . 2014 Feb; 63(4):407-18. PMID: 24514956
We recently reported the clinical results of a Phase I trial combining ipilimumab with a vaccine containing transgenes for prostate-specific antigen (PSA) and for a triad of costimulatory molecules (PROSTVAC)...